Chylous acid that develops after COVID-19 infection in a patient with ovarian cancer

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

One of the most common symptoms of ovarian cancer is ascites and can be controlled by surgery and chemotherapy. Acid palliation is provided with paracentesis and diuretic therapy in treatment-resistant patients. Chylous acid is rarely detected in the course of ovarian cancer and it mostly develops due to lymphatic system damage due to surgery or radiotherapy. Chylous acid due to disease progression is an extremely rare phenomenon. A 71-year-old woman with metastatic ovarian cancer presented with abdominal distension and milky acid. The patient has not received chemotherapy for about 3 months due to COVID-19 infection. After the infectious causes were excluded, the patient was started second line therapy and it was observed that chylous acid regressed. When chylous acid is detected in a cancer patient, infectious causes should be excluded quickly and systemic anti-cancer treatment should be initiated.

Cite

CITATION STYLE

APA

Sezer, B., Sütçüoğlu, O., & Özdemir, N. (2021). Chylous acid that develops after COVID-19 infection in a patient with ovarian cancer. Gazi Medical Journal, 32(4), 593–595. https://doi.org/10.12996/GMJ.2021.134

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free